Publication | Closed Access
A 2-year randomised, double-blind, placebo-controlled, multicentre study of oral selective iNOS inhibitor, cindunistat (SD-6010), in patients with symptomatic osteoarthritis of the knee
131
Citations
40
References
2012
Year
| Year | Citations | |
|---|---|---|
Page 1
Page 1